<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Born under a Bad Sign</title>
	<atom:link href="http://blog.pharmtech.com/2008/08/25/born-under-a-bad-sign/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2008/08/25/born-under-a-bad-sign/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Erik Greb</title>
		<link>http://blog.pharmtech.com/2008/08/25/born-under-a-bad-sign/comment-page-1/#comment-5786</link>
		<dc:creator>Erik Greb</dc:creator>
		<pubDate>Tue, 26 Aug 2008 14:42:56 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=179#comment-5786</guid>
		<description>The remark about Vytorin potentially causing blockage in the carotid artery was not based on the Enhance trial&#039;s results, but on an Associated Content article. I couldn&#039;t find a separate source that repeated or explained the basis for that claim, so I struck the remark from my post. Thanks for keeping me honest.</description>
		<content:encoded><![CDATA[<p>The remark about Vytorin potentially causing blockage in the carotid artery was not based on the Enhance trial&#8217;s results, but on an Associated Content article. I couldn&#8217;t find a separate source that repeated or explained the basis for that claim, so I struck the remark from my post. Thanks for keeping me honest.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: CDN_MD</title>
		<link>http://blog.pharmtech.com/2008/08/25/born-under-a-bad-sign/comment-page-1/#comment-5679</link>
		<dc:creator>CDN_MD</dc:creator>
		<pubDate>Mon, 25 Aug 2008 21:02:56 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=179#comment-5679</guid>
		<description>&quot;...including evidence that it can cause blockage in the carotid artery.&quot; Erik, you might wish to actually read the clincial trial before making a statement such as this. If you had, you would know that this statement is completely misleading and false. The ENHANCE study compared 40mg of simvastatin to 40mg simvastatin/10mg ezetimibe and showed there was no additional clearing of the carotid artery as a result of the combo vs. simvaststin alone. A BIG difference from the statement you have made above. You might wish to check your facts before publishing junk.</description>
		<content:encoded><![CDATA[<p>&#8220;&#8230;including evidence that it can cause blockage in the carotid artery.&#8221; Erik, you might wish to actually read the clincial trial before making a statement such as this. If you had, you would know that this statement is completely misleading and false. The ENHANCE study compared 40mg of simvastatin to 40mg simvastatin/10mg ezetimibe and showed there was no additional clearing of the carotid artery as a result of the combo vs. simvaststin alone. A BIG difference from the statement you have made above. You might wish to check your facts before publishing junk.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
